L-arginine
- Generic Name
- L-arginine
- Brand Names
- Clinimix 2.75/5
- Drug Type
- Small Molecule
- CAS Number
- 74-79-3
L-Arginine Metabolism in Essential Hypertension
Phase 2
Completed
- Conditions
- Essential Hypertension
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Target Recruit Count
- 120
- Registration Number
- NCT00137124
- Locations
- 🇩🇪
CRC, Medizinische Klinik 4 - Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen, Germany
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
Phase 1
Completed
- Conditions
- Sickle Cell Anemia
- First Posted Date
- 2003-03-13
- Last Posted Date
- 2019-11-22
- Target Recruit Count
- 39
- Registration Number
- NCT00056433
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Vascular Interaction With Age in Myocardial Infarction
Not Applicable
Completed
- Conditions
- Myocardial Infarction
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
Phase 2
Completed
- Conditions
- HypercholesterolemiaPostmenopause
- First Posted Date
- 2002-12-10
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 30
- Registration Number
- NCT00001752
- Locations
- 🇺🇸
National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath